TVTX and LGND Related Headlines

Go Back

Apr 14, 2026 07:00AM FDA approves FILSPARI for rare kidney disease FSGS

Apr 14, 2026 07:00AM Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS

Mar 24, 2026 05:03AM Citi Adjusts Catalyst Call List

TVTX and LGND Related Press Releases

Go Back

Apr 14, 2026 07:00AM Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS

TVTX and LGND Related SEC Filings

Go Back